Jurkat E6.1（人急性T細胞白血病細胞）
CBP60942
詢 價
Jurkat E6.1 全景
產品描述
產品數據庫
| I. General information | |
| Synonyms: | Jurkat E6.1 |
| Background: | The Jurkat cell line was established from the peripheral blood of a 14 year old boy by Schneider et al., and was originally designated JM. The line was cloned from cells obtained from Dr. Kendall Smith and are mycoplasma free. This is a clone of the Jurkat-FHCRC cell line, a derivative of the Jurkat cell line. |
| Species: | Homo sapiens, human |
| Tissue: | peripheral blood |
| Disease: | acute T cell leukemia |
| Gender: | male |
| Morphology: | lymphoblast |
| Growth Mode: | suspension |
| Doubling Time: | 48 hrs |
| DNA Profile: | Amelogenin: X,Y CSF1PO: 11,12 D13S317: 8,12 D16S539: 11 D5S818: 9 D7S820: 8,12 THO1: 6,9.3 TPOX: 8,10 vWA: 18 Our Cell Line Authentication Service |
| Culture Medium: |
RPMI-1640+10%FBS Jurkat E6.1完全培養(yǎng)基，# CBP60942M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Antigen Expression: | CD3; Homo sapiens, expressed |
| Receptor Expression: | T cell antigen receptor, expressed |
| Genes Expressed: | interleukin-2 (interleukin 2, IL-2),CD3; Homo sapiens, expressed |
| Comments: | Clone E6-1 cells produce large amounts of IL-2 after stimulation with phorbol esters and either lectins or monoclonal antibodies against the T3 antigen (both types of stimulants are needed to induce IL-2 production. For more information, please contact us (4008-750-250). |
